Michael Buhle

Form D signer

Michael Buhle

Chief Executive Officer at Aspira Women's Health

Form D signer

Capital raised by Aspira Women's Health

$5.8M+$1.5M latest round

3 Form D filings · first filed Mar 2025 · Austin, TX

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 3
TEAM ON FILE: 4
FOUNDED: —
30D INTEREST: 2 ↗

Career

1 company on file

Aspira Women's HealthBiotech · Austin, TXsince Mar 2025

Chief Executive Officer

Signatory on Aspira Women's Health's Form D filings · $5.8M raised across 3

Company filings

via EDGAR · Form D for Aspira Women's Health3

DateCompanyFormAmountRole on filing

Jun 5, 2026Aspira Women's HealthForm D+$1.5MChief Executive Officer

Form DJun 5, 2026 · Aspira Women's Health+$1.5Mas Chief Executive Officer

Sep 16, 2025Aspira Women's HealthForm D+$3.0MChief Executive Officer

Form DSep 16, 2025 · Aspira Women's Health+$3.0Mas Chief Executive Officer

Mar 5, 2025Aspira Women's HealthForm D+$1.4MChief Executive Officer

Form DMar 5, 2025 · Aspira Women's Health+$1.4Mas Chief Executive Officer

Overview

Last filing Jun 5, 2026

Michael Buhle is on file as Chief Executive Officer at Aspira Women's Health in Austin, TX. Aspira Women's Health has 3 Form D filings on record, $5.8M raised in total. Michael Buhle appears as a signatory on the company's filings.

Teammates

Aspira Women's Health · 3

Ellen BeausangDirector John StrahleyChief Financial OfficerSigner Winfred ParnellDirector

Products

Aspira Women's Health · 1

OvaSuiteDiagnostic Blood Tests

OvaSuite is a comprehensive suite of blood tests designed to aid in the assessment of ovarian cancer risk. It includes specific tests tailored to monitor and evaluate the presence of malignancy in adnexal masses.